NEW_CURA-LEAF_1170x120_OCT

America’s drug chains

The leaders are there; who will stand out in chain drug?

The leaders are there; who will stand out in chain drug?

Going into the new year, several key personnel questions await answers, foremost among them the age-old problem of determining who, in 2017, will emerge as the most influential senior staffers at America’s drug chains. The determination is made more difficult by the fact that, as of this writing, Walgreens’ acquisition of Rite Aid remains unresolved.